Fibroscan - Fatty liver and liver fibrosis examination special promotion offer


1/29/20242 min read

Fatty liver disease and liver fibrosis are two diseases related to liver health. Fibroscan is a non-invasive examination method used to evaluate the degree of fatty liver and liver fibrosis, giving the examiner two independent evaluation indexes.

Fatty liver disease is a condition in which excess fat accumulates in liver cells. It is generally divided into two types: non-alcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (ALD). NAFLD is often associated with metabolic symptoms such as obesity, diabetes, high blood pressure, and high cholesterol, while ALD is associated with chronic heavy drinking. If fatty liver disease is not effectively managed, it may progress to liver fibrosis.

Liver fibrosis refers to the increase of fibrous connective tissue in liver tissue. It often occurs in patients with hepatitis B or C, those who take too many drugs and drink heavily for a long time. This is a reaction during the repair process of liver damage. When chronic liver disease progresses, fibrous connective tissue will gradually replace normal liver tissue, thus affecting liver function. The degree of liver fibrosis can be graded in several stages from no fibrosis to different degrees of fibrosis, and may eventually evolve into cirrhosis or liver cancer.

Fibroscan is a non-invasive test using ultrasound to assess the extent of fatty liver disease and liver fibrosis. It assesses the severity of fatty liver disease and fibrosis by measuring the elasticity of liver tissue. During the test, the doctor or nurse will place a probe-like device over the liver area and send slight mechanical vibrations to measure how quickly these vibrations propagate through the liver tissue. From these propagation velocities, the degree of elasticity and fibrosis of the liver can be inferred.

The numerical results of Fibroscan are usually transient elastography VCTE liver stiffness to assess liver fibrosis and controlled attenuation parameter CAP to assess liver fat content. These indicators can help doctors assess the health of the liver and guide treatment decisions.

However, it should be noted that Fibroscan results are only a US FDA-approved method to evaluate fatty liver and liver fibrosis and cannot provide a detailed diagnosis of liver lesions. Early detection can help prevent cirrhosis and fatty liver problems from getting worse. Don’t miss the golden period to reverse liver disease!

If you suspect that you have fatty liver or liver fibrosis, it is recommended that you seek medical advice and diagnosis as soon as possible. They can develop a treatment plan that's right for you based on your medical history, symptoms, and test results.

Fibroscan test discount promotion price: HKD 1,200

The price includes:

  • Examination at Central Endocrinology and Diabetes Specialist Clinic

  • Endocrinology and diabetes medical specialist doctor will interpret the report and make recommendations

To learn more, click here:

Welcome to call or WhatsApp 95451010 for inquiries/appointments